World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
47404
World Ranking
582
National Ranking
346

Medicine

D-Index
106
Citations
47785
World Ranking
6453
National Ranking
3432

Mario Castro publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mario Castro sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 454 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mario Castro D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mario Castro sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mario Castro is affiliated with Washington University in St. Louis in the United States and specializes in medical research with a focus on pulmonary and respiratory medicine.

Their primary field of study is Medicine, with significant contributions in the following subfields:

  • Pulmonary and Respiratory Medicine
  • Physiology
  • Immunology
  • Surgery
  • Infectious Diseases

The main research topics Mario Castro has worked on include:

  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • IL-33, ST2, and ILC Pathways
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inhalation and Respiratory Drug Delivery
  • Eosinophilic Esophagitis
  • Allergic Rhinitis and Sensitization

They have published extensively in several academic journals. Frequent publication venues include:

  • American Journal of Respiratory and Critical Care Medicine
  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • CHEST Journal
  • bioRxiv (Cold Spring Harbor Laboratory)

Noteworthy recent papers by Mario Castro include:

  • COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids (2020, American Journal of Respiratory and Critical Care Medicine)
  • Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency (2020, American Journal of Respiratory and Critical Care Medicine)
  • Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation (2021, European Respiratory Journal)
  • Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety (2020, European Respiratory Review)
  • Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time (2022, American Journal of Respiratory and Critical Care Medicine)

Mario Castro has collaborated frequently with several co-authors in the field, including:

  • Elliot Israel
  • Sally E. Wenzel
  • Bruce D. Levy
  • Nizar N. Jarjour
  • Serpil C. Erzurum

Best Publications

  • International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

    Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush

  • Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

    Wendy C. Moore;Deborah A. Meyers;Sally E. Wenzel;W. Gerald Teague

  • Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero

  • Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

    Mario Castro;James Zangrilli;Michael E Wechsler;Eric D Bateman

  • Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

    Klaus F. Rabe;Parameswaran Nair;Guy Brusselle;Jorge F. Maspero

  • Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

    Sally Wenzel;Mario Castro;Jonathan Corren;Jorge Maspero

  • Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

    Wendy C. Moore;Eugene R. Bleecker;Douglas Curran-Everett;Serpil C. Erzurum

  • Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

    Dara G. Torgerson;Dara G. Torgerson;Elizabeth J. Ampleford;Grace Y. Chiu;W. James Gauderman

  • Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: A multicenter, randomized, double-blind, sham-controlled clinical trial

    Mario Castro;Adalberto S. Rubin;Michel Laviolette;Jussara Fiterman

  • Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-Controlled Study

    Mario Castro;Sameer Mathur;Frederick Hargreave;Louis-Philippe Boulet

  • Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

    Yvonne J. Huang;Craig E. Nelson;Eoin L. Brodie;Todd Z. DeSantis

  • Tiotropium bromide step-up therapy for adults with uncontrolled asthma

    Stephen P. Peters;Susan J. Kunselman;Nikolina Icitovic;Wendy C. Moore

  • Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.

    Edy Y Kim;John T Battaile;Anand C Patel;Yingjian You

  • Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

    Fernando Holguin;Juan Carlos Cardet;Kian Fan Chung;Sarah Diver

  • Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program.

    Anne M. Fitzpatrick;W. Gerald Teague;Deborah A. Meyers;Stephen P. Peters

  • Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction

    Eleanor M. Dunican;Brett M. Elicker;David S. Gierada;Scott K. Nagle

  • Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

    Mario Castro;Sally E Wenzel;Eugene R Bleecker;Emilio Pizzichini

  • Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts

    Michael C Peters;Kelly Wong McGrath;Gregory A Hawkins;Annette T Hastie

  • Obesity and asthma, an association modified by age of asthma onset

    Fernando Holguin;Eugene R. Bleecker;William W. Busse;William J. Calhoun

  • Efficacy of esomeprazole for treatment of poorly controlled asthma.

    John G. Mastronarde;Nicholas R. Anthonisen;Mario Castro

  • COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.

    Michael C. Peters;Satria Sajuthi;Peter Deford;Stephanie Christenson

Frequent Co-Authors

Sally E. Wenzel
Sally E. Wenzel University of Pittsburgh
Elliot Israel
Elliot Israel Brigham and Women's Hospital
Eugene R. Bleecker
Eugene R. Bleecker University of Arizona
Nizar N. Jarjour
Nizar N. Jarjour University of Wisconsin–Madison
Serpil C. Erzurum
Serpil C. Erzurum Cleveland Clinic Lerner College of Medicine
Wendy C. Moore
Wendy C. Moore Wake Forest University
William W. Busse
William W. Busse University of Wisconsin–Madison
Stephen P. Peters
Stephen P. Peters Wake Forest University
John V. Fahy
John V. Fahy University of California, San Francisco
Benjamin Gaston
Benjamin Gaston Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees online can open diverse career opportunities. Many professionals explore advanced nursing roles, complementing their understanding of the immune system with clinical expertise. For example, the cheapest pmhnp programs offer affordable paths into psychiatric nursing, integrating mental health with biological science knowledge.

Understanding the financial aspect is also crucial. Nurses with a Doctor of Nursing Practice (DNP) often look for competitive salaries, which vary by location. Reviewing data on how much do dnp nurses make helps candidates make informed decisions about where to work or study.

For those aiming to specialize further, transitioning roles is a common route. Nurses interested in acute care can explore pathways like the acute care certification for fnp. This helps expand their scope and work in critical care settings.

Students seeking efficiency in education might consider fast-track routes through an accelerated fnp program, allowing them to enter the workforce sooner while maintaining quality training.

Best Scientists Citing Mario Castro

Trending Scientists

Recently Published Articles